Literature DB >> 7713916

Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain.

L Wei1, S R Hubbard, W A Hendrickson, L Ellis.   

Abstract

The deduced primary sequence of the cytoplasmic protein-tyrosine kinase domain of the insulin receptor contains a conserved kinase homology region (receptor residues 1002-1257) flanked by a juxtamembrane region and a C-terminal tail. A soluble 48-kDa derivative (residues 959-1355) containing these regions but lacking the first six residues of the juxtamembrane region had earlier been synthesized in Sf9 cells using a baculovirus expression system. The catalytic core of the kinase domain was studied first by proteolytic analysis of the 48-kDa kinase and then by expressing a series of truncated kinase domains in transiently transfected COS cells. Based on these studies, two core kinases of 34 (residues 985-1283) and 35 (residues 978-1283) kDa, respectively, were overexpressed in Sf9 cells. Biochemical characterization of the 35-kDa kinase revealed that the core kinase conserved the major functional properties of the native receptor kinase domain. Activity of the 35-kDa kinase toward a synthetic peptide increased more than 200-fold upon autophosphorylation, which occurred exclusively at Tyr-1158, Tyr-1162, and Tyr-1163; the largest increase was observed between bis- and trisphosphorylation of the kinase. The activated 35- and 48-kDa kinases were similar with respect to specific activity and ATP and Mg2+ requirements for peptide phosphorylation. Moreover, autophosphorylation appeared to initiate predominantly at Tyr-1162, immediately followed by phosphorylation at Tyr-1158 and then at Tyr-1163. The rate of autophosphorylation was dependent on enzyme concentration, consistent with a trans-phosphorylation mechanism. Finally, the 35-kDa kinase was crystallized, making possible elucidation of its three-dimensional structure by x-ray crystallography.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713916     DOI: 10.1074/jbc.270.14.8122

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  "DFG-flip" in the insulin receptor kinase is facilitated by a helical intermediate state of the activation loop.

Authors:  Harish Vashisth; Luca Maragliano; Cameron F Abrams
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

2.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.

Authors:  S R Hubbard
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  Mechanism of activation for Zap-70 catalytic activity.

Authors:  P V LoGrasso; J Hawkins; L J Frank; D Wisniewski; A Marcy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 4.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

Review 5.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

6.  Conformational changes in the activation loop of the insulin receptor's kinase domain.

Authors:  M Frankel; S M Bishop; A J Ablooglu; Y P Han; R A Kohanski
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

7.  Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

Authors:  S L Sierke; K Cheng; H H Kim; J G Koland
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

8.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 9.  The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.

Authors:  Stevan R Hubbard
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

10.  Effect of thiol antioxidant on body fat and insulin reactivity.

Authors:  Wulf Hildebrandt; Andreas Hamann; Holger Krakowski-Roosen; Ralf Kinscherf; Klaus Dugi; Roland Sauer; Sabrina Lacher; Nuria Nöbel; Anne Bodens; Vassiliki Bellou; Lutz Edler; Peter Nawroth; Wulf Dröge
Journal:  J Mol Med (Berl)       Date:  2004-03-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.